Skip to search formSkip to main contentSkip to account menu

cyclophosphamide/dexrazoxane/doxorubicin/oblimersen

Known as: ADR-529/CTX/DOX/G3139 
National Institutes of Health

Related topics

Related topics

6 relations
CyclophosphamideDexrazoxaneDexrazoxane hydrochlorideDoxorubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Multifunctional liposomes for enhanced anti-cancer therapy
i ACKNOWLEDGMENTS iii LIST OF TABLES vii LIST OF FIGURES viii LIST OF ABREVIATIONS xi 1) INTRODUCTION 1 1.1. Statement of the… 
2007
2007
Comparison of d-g3139 and its enantiomer L-g3139 in melanoma cells demonstrates minimal in vitro but dramatic in vivo chiral dependency.
G3139 (Genasense), an 18mer phosphorothioate antisense oligonucleotide targeted to the initiation codon region of the Bcl-2… 
2005
2005
Cellular Uptake and Intracellular Levels of the Bcl-2 Antisense G 3139 in Cultured Cells and Treated Patientswith AcuteMyeloid Leukemia
Purpose:Down-regulation of Bcl-2 by the antisense G3139, currently under clinical evaluations, could restore chemosensitivity in… 
2002
2002
Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells.
2001
2001
Cationic lipids enhanced cellular uptake and activity of bcl-2 antisense oligodeoxynucleotide G3139 in HL-60 cells.
AIM To explore the effect of cationic lipid 1,3-di-oleoyloxy-2-(6-carboxy-spermyl)-propylamid (DOSPER) on cellular uptake and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)